Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases.
Lauko A, Kotecha R, Barnett A, Li H, Tatineni V, Ali A, Patil P, Mohammadi AM, Chao ST, Murphy ES, Angelov L, Suh JH, Barnett GH, Pennell NA, Ahluwalia MS.
Lauko A, et al. Among authors: suh jh.
Sci Rep. 2021 Sep 13;11(1):18174. doi: 10.1038/s41598-021-97566-z.
Sci Rep. 2021.
PMID: 34518623
Free PMC article.